Radiopharmaceuticals 样本条款

Radiopharmaceuticals. Radiopharmaceuticals prescribed by basically Act on Ensuring Quality, Effectiveness and Safety of Pharmaceuticals and Medical Devices,etc. (Act No. 145 of August 10, 1960) Their radionuclides were prescribed by the Atomic Energy Basic Act (Act No.186 of December 19, 1955) and they were also approved under Act on Ensuring Quality, Effectiveness and Safety of Pharmaceuticals and Medical Devices,etc. Radiopharmaceuticals are used mainly for injections, namely “in vivo use”. The assay kits containing radiolabeled compounds are also described as radiopharmaceuticals, namely “in vitro use” as long as they are used for clinical examinations. Radiopharmaceuticals are, here, described as “in vivo” for clinical diagnosis and therapy , and “in vitro” for diagnostic assays. Ⅲ Symbols The following symbols are used in the tables. ‐ :Nil ・ :Class or item not applicable 0 :Figure less than 0.5 Ⅳ Districts and Prefectures The following serial number is given to each prefecture. 01 Hokkaido 24 Mie Prefecture 02 Aomori Prefecture 25 Shiga Prefecture 04 Miyagi Prefecture 27 Osaka Prefecture 06 Yamagata Prefecture 29 Nara Prefecture 07 Fukushima Prefecture 30 Wakayama Prefecture 09 Tochigi Prefecture 32 Shimane Prefecture 10 Gunma Prefecture 33 Okayama Prefecture 11 Saitama Prefecture 34 Hiroshima Prefecture 12 Chiba Prefecture 35 Yamaguchi Prefecture 13 Tokyo 36 Tokushima Prefecture 16 Toyama Prefecture 39 Kochi Prefecture
Radiopharmaceuticals. Radiopharmaceuticals prescribed by basically Act on Ensuring Quality, Effectiveness and Safety of Pharmaceuticals and Medical Devices,etc. (Act No. 145 of August 10, 1960) Their radionuclides were prescribed by the Atomic Energy Basic Act (Act No.186 of December 19, 1955) and they were also approved under Act on Ensuring Quality, Effectiveness and Safety of Pharmaceuticals and Medical Devices,etc. Radiopharmaceuticals are used mainly for injections, namely “in vivo use”. The assay kits containing Ⅳ radiolabeled compounds are also described as radiopharmaceuticals, namely “in vitro use” as long as they are used for clinical examinations. Radiopharmaceuticals are, here, described as “in vivo” for clinical diagnosis Ⅳ and therapy , and “in vitro” for diagnostic assays.

Related to Radiopharmaceuticals

  • IVD 血液 (血清/血浆) 阴性/阳性(滴度) --

  • JICA はい、そうです。

  • URL xxxx://xxx.xxxxxx-xxxxx.xx.xx/

  • IPA担当者使用欄 提出書類 部数 有無 No. 提出書類 部数 有無

  • Point PFS事業を実施した地方公共団体職員の声 PFS事業を実施した地方公共団体職員の声 公募書類の作成

  • 合同对上市公司的影响 项目如能顺利实施,预计将对公司未来经营业绩产生积极影响。该合同的签订属于公司日常经营事项,不会造成公司对单一客户的重大依赖,不会对公司业务的独立性产生不利影响。

  • 信用记录 供应商未被列入“信用中国”网站(xxx.xxxxxxxxxxx.xxx.xx)“记录失信被执行人或重大税收违法案件当事人名单”记录名单; 不处于中国政府采购网(www.ccgp.go x.xx)“政府采购严重违法失信行为信息记录 中的禁止参加政府采购活动期间。 (以采购代理机构于投标(响应) 截止时间当天在“信用中国”网站(www.creditchi xx.xxx.xx) 及中国政府采购网(xxxx://xxx.xxxx.xxx.xx/) 查询结果为准, 如相关失信记录已失效, 供应商需提供相关证明资料) 。 7 供应商必须符合法律、行政法规规定的其他条件 单位负责人为同一人或者存在直接控股、 管理关系的不同供应商,不得同时参加本采购项目(或采购包) 投标(响应)。 为本项目提供整体设计、 规范编制或者项目管理、 监理、 检测等服务的供应商, 不得再参与本项目投标(响应)。 投标( 报价) 函相关承诺要求内容。

  • 規定の変更 (1) この規定の各条項その他の条件は、金融情勢の状況の変化その他相当の事由があると認められる場合には、当行ホームページへの掲載による公表その他相当の方法で周知することにより、変更できるものとします。 (2) 前項の変更は、公表等の際に定める適用開始日から適用されるものとします。

  • 規定の準用 この規定の定めのない事項についてカード規定に定めがある場合には、カード規定により取扱います。

  • 采购内容及技术要求 序号 内容 说明和要求 1 人员到岗及履约要求 (